Prostate cancer often manifests as morphologically distinct tumour foci and is frequently found adjacent to presumed precursor lesions such as high-grade prostatic intraepithelial neoplasia (HGPIN). While there is some evidence to suggest that these lesions can be related and exist on a pathological and morphological continuum, the precise clonal and temporal relationships between precursor lesions and invasive cancers within individual tumours remain undefined. Here, we used molecular genetic, cytogenetic, and histological analyses to delineate clonal, temporal and spatial relationships between HGPIN and cancer lesions with distinct morphological and molecular features. First, while confirming the previous finding that a substantial fraction of HGPIN lesions associated with ERG-positive cancers share rearrangements and overexpression of ERG, we found that a significant subset of such HGPIN glands exhibit only partial positivity for ERG suggesting that such ERG-positive HGPIN cells either rapidly invade to form adenocarcinoma or represent cancer cells that have partially invaded the ductal and acinar space in a retrograde manner. To clarify these possibilities, we used ERG expression status and TMPRSS2-ERG genomic breakpoints as markers of clonality, and PTEN deletion status to track temporal evolution of clonally related lesions. We confirmed that morphologically distinct HGPIN and nearby invasive cancer lesions are clonally related. Further, we found that a significant fraction of ERG-positive, PTEN-negative HGPIN and intraductal carcinoma (IDC-P) lesions are most likely clonally derived from adjacent PTENnegative adenocarcinomas indicating that such PTEN-negative HGPIN and IDC-P lesions arise from, rather than give rise to, the nearby invasive adenocarcinoma. These data suggest that invasive adenocarcinoma can morphologically mimic HGPIN through retrograde colonization of benign glands with cancer cells. Similar clonal relationships were also seen for intraductal carcinoma adjacent to invasive adenocarcinoma. These findings represent a potentially undervalued indicator of pre-existing invasive prostate cancer and have significant implications for prostate cancer diagnosis and risk stratification.
INTRODUCTION
Prostate cancer is characterized by significant intra-and inter-tumour heterogeneity at the genomic and morphological levels (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . Deciphering the clonal and temporal relationships between precursor lesions and morphologically and genetically distinct invasive carcinomas represents a major challenge in prostate cancer molecular pathology. The generally accepted precursor to the the majority of invasive adenocarcinomas of the prostate is high grade prostatic intraepithelial neoplasia (HGPIN). HGPIN is defined by the presence of neoplastic appearing cells present within pre-existing acini and ducts that are confined by a surrounding layer of basal cells (11, 12) . Several lines of evidence have suggested that HGPIN may represent a precusor to invasive cancer. HGPIN is often found in close proximity to invasive adenocarcinomas and it shares a number of defining morphological features with invasive adenocarcinomas such as nuclear and nucleolar enlargement (11, 12) . Further, the presence of extensive HGPIN on prostate needle biopsy is associated with an elevated risk of cancer on subsequent biopsies (13) (14) (15) (16) ; invasive "microcarcinomas" at times appear to arise from HGPIN lesions (17) ; HGPIN and adenocarcinoma share a number of molecular features (11, (18) (19) (20) ; and HGPIN lesions share a number of somatic genetic and epigenetic alterations with invasive prostatic adenocarcinomas (4, 6, 11, (21) (22) (23) (24) (25) (26) (27) . It is important to note, however, that most of the previous studies evaluating somatic DNA alterations in HGPIN and adjacent cancers used low resolution and mostly fluorescence in situ hybridization (FISH) based approaches, which although suggestive of a common clonal relationship between HGPIN and invasive carcinomas, did not allow a definitive evaluation of clonal ancestry. Furthermore, the small size of most HGPIN lesions, their frequent tight physical proximity to invasive cancer, and the lack of refined analytical tools has hampered more in-depth molecular analyses. Finally, unlike potential precancerous lesions present in other organs, the temporal and clonal relationship of HGPIN progression to adenocarcinoma has proven difficult to assess due to the virtual impossibility of serially sampling individual HGPIN lesions in an individual prostate.
Among the most common genomic alterations in prostate cancer are structural rearrangements involving TMPRSS2 and ERG, which can be found in ~50% of cases (28, 29) . TMPRSS2-ERG rearrangements result in the overexpression of the oncogenic transcription factor ERG and represent an early event in prostate cancer progression. This notion is based on the observation that TMPRSS2-ERG rearrangements are generally pervasive within an individual tumour such that virtually all invasive tumour cells have the same cytogenetically defined rearrangement (28, (30) (31) (32) (33) . At a higher resolution, genomic rearrangement breakpoints between TMPRSS2 and ERG can be used as a rigorous marker of clonality because, despite the presence of regional rearrangement hotspots (34, 35) , every TMPRSS2-ERG breakpoint identified thus far is unique within each individual, and each clonally distinct tumour focus (2, 34, 36) . To date, however, no studies showing clonal breakpoints in TMPRSS2-ERG or other ETS fusion genes have been reported in human HGPIN lesions.
Another frequently observed alteration in prostate cancer genomes involves the loss of the tumour suppressor gene PTEN. The most common mechanism of PTEN loss involves deletion (2, 26) .
Importantly for the present study, a number of different groups have shown that PTEN loss generally occurs subsequent to ETS gene fusions in those cancers that harbour ETS gene fusions (2, 7, 36, 37) ;
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PTEN loss often occurs subclonally in a subset of cancer glands within a cancer focus, further supporting the notion that PTEN loss is a later event in tumour progression (2, 7, 36, 37) associated with more aggressive disease (38) (39) (40) (41) . As genomic elements that have been eliminated by homozygous deletion cannot easily be regained, differing PTEN loss status between morphologically distinct, but clonally related lesions can provide information on the temporal vector that underlies the clonal evolutionary relationships between each lesion.
Several groups have previously noted that HGPIN lesions in close proximity to ERG-positive tumours display a high rate of ERG rearrangements. Isolated HGPIN lesions located at a distance from any invasive lesions, however, rarely contain ERG rearrangements (32, 33, 42, 43) . This pattern of adjacent versus distal alterations in HGPIN lesions with regard to primary adenocarcinoma foci has also been noted with regards to PTEN status (32, 41, 44) . These findings of common ERG rearrangements in It is widely accepted among genitourinary pathologists that intraductal carcinoma (IDC-P), a lesion that is diagnosed based on the presence of highly atypical neoplastic cells in a cribriform architecture that shows marked acinar/glandular expansion and is surrounded by basal cells, most likely represents invasion of established invasive adenocarcinoma into normal glandular structures (44, (46) (47) (48) (49) (50) .
A recent case report provided the first direct evidence for the close clonal relationship between IDC-P, adjacent carcinoma and concurrent metastatic lesions (51) . However, direct high-resolution genetic evidence showing that morphologically apparent IDC-P represents spread from an adjacent carcinoma has not been provided in a larger study. Nonetheless, there has been an extensive discussion on intraductal spreading pattern which morphologically shows defining features of IDC-P (46,49,50,52). Here we studied the clonal and temporal relationships of HGPIN and co-occurring invasive cancer lesions by using an integrated approach using immunohistochemistry, FISH and molecular genetic approaches. Our results suggest that the majority of PTEN-negative HGPIN and IDC-P lesions, when present in close proximity to invasive carcinoma, more likely represent cancer cells that have invaded adjacent normal ductal and acinar structures than de novo precursor lesions.
MATERIALS AND METHODS

Patient Samples
This study was approved by the Johns Hopkins Medicine Institutional Review Board. Forty-eight ERGpositive cancers were selected for this study to map topographical relationships between HGPIN and adenocarcinoma lesions by ERG IHC from the index lesion of totally embedded radical prostatectomy specimens. In addition to these cases, in seven additional cases for which TMPRSS2-ERG rearrangement breakpoints were previously determined from the index lesion using DNA obtained from macrodissected fresh frozen tumour material, (34) individual areas from adjacent FFPE tissues containing normal epithelium, HGPIN, IDC-P or invasive adenocarcinoma were microdissected and analyzed as described below. Note that in all 7 cases the invasive lesions showed uniform ERG positivity. HGPIN was classified according to Bostwick et al. (18) . In contrast to HGPIN, IDC-P was defined as lesions confined by a partial or intact basal cell lining filling expanded acini/ducts in either a dense cribriform or micropapillary pattern with marked nuclear atypia (e.g. 6X times normal) or comedonecrosis (48) Given that there is a spectrum of morphologies ranging from cribriform PIN to IDC-P, subsequent authors have suggested to include similar cribriform expansive lesions surrounded by basal cells, but that have less nuclear atypia, as IDC-P if they are in close proximity to carcinoma and we have used this definition here (47, 53) . Lesions that showed cribriform formations without duct/acinar expansion and without 6X nuclear enlargement were still considered cribriform PIN. Topographical relationships were scored as described by Putzi et al (54) with regards to proximity to an index carcinoma lesion: "adjacent" defined as being within 100 μm, "near" defined as being between 100 μm to 1 mm away, and "far" defined as being more than 1 mm away. Note that the topographical proximity was measured on a single representative section of the index tumour. Since no 3D reconstruction was attempted, the distance measurements do not capture complex spatial relationships between different lesions. Clinicopathological characteristics are summarized in Table 1 .
IHC and FISH
Immunolabelling for ERG and PTEN was performed as described (33, 40) . Dual colour immunohistochemical staining was performed using mouse monoclonal anti-ERG or rabbit monoclonal 
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Micrographs shown in the supplementary materials were taken from slides co-labelled for PTEN, ERG, p63 and 34Be12/903 as described previously (44) . PTEN status and nuclear ERG status were scored based on established criteria (33, 40) . Fluorescence in situ hybridization (FISH) for PTEN deletion was performed on adjacent sections using commercially available probes (PTEN del-TECT Four Color FISH Probe, CymoGen Dx LLC, Irvine, CA, USA) and was evaluated as previously described (7).
LCM, DNA extraction and PCR Detection of Rearrangements
Representative areas from indicated lesions and matched normal glands from each patient were microdissected using a PALM MicroLaser System and PALM membrane slides (Carl Zeiss, Germany) and DNA was extracted as described (3) . DNA samples were analyzed by PCR for the presence of previously identified case specific TMPRSS2-ERG rearrangements using breakpoint-flanking primers.
PCR products were analyzed by Sanger sequencing (34) (Supplementary Table 2 ).
RESULTS
In order to investigate the clonal relationships between invasive adenocarcinomas and nearby HGPIN lesions, we evaluated their spatial distribution and their ERG staining pattern in a group of 48 ERGpositive prostate cancers using ERG-specific immunohistochemistry ( Table 1) . As documented previously by us and others (7, 33) , all of these ERG-positive cases showed immunolabelling in all tumour cells using ERG-specific antibodies ( Figure 1A ). Of these cases containing ERG-positive tumours, 41/48 (85%) contained HGPIN, of which 31/41 were "adjacent" (<100 μm) to the carcinoma, 19/41 were "near" the carcinoma (100 μm to 1 mm) and 11/41 were "far" (> 1mm) from the index cancer lesion ( Table 1) In the majority of cases with HGPIN (36/37, 97%) we also observed glandular lesions with only partial involvement of ERG-positive HGPIN cells, distinguished by the presence of enlarged nuclei and distinct nucleoli and often with cytoplasmic basophilia characteristic of PIN. Such lesions occurred more frequently in close proximity to invasive carcinoma. In these cases positive staining for ERG also occurred in the neoplastic appearing cells, whereas the remaining benign appearing cells within the acini had no detectable ERG expression ( Figure 1C, D, Supplementary Figure 1) . Of note, neoplastic-appearing ERG-positive cells were also observed at times in atrophic glands (Supplementary Figure 2) . For all of these lesions the diagnosis of "HGPIN partially involving an individual gland", was rendered. Overall, 36/48 (75%) cases showed partial ERG-positive glands. This phenotype showed no relationship to Gleason grade, and partially involved glands were found in both high-grade and low-grade lesions (Supplementary Figure 3) . ERG-positive HGPIN lesions, whether partially-or fully-involving glands that were in very close proximity to invasive carcinoma, suggest two main distinct temporal and topographic progression scenarios. In the first, these ERG-positive HGPIN containing glands reflect de novo intraepithelial lesions, which at times have not yet fully replaced cells of the normal glandular structure (i.e. partially-positive HGPIN glands), but have nonetheless produced progeny cells that already invaded into the surrounding stroma forming invasive adenocarcinoma. In the second scenario, ERG-positive cells with the appearance of HGPIN are derived from an established invasive adenocarcinoma that have invaded, in a retrograde manner, the glandular space to colonize the epithelial layer of a pre-existing acinus and/or duct.
In order to distinguish between these possibilities we performed high-resolution molecular pathology studies using both the detection of TMPRSS2-ERG fusion genomic breakpoints by PCR as well as PTEN genomic loss detected by IHC and confirmed by FISH. We reasoned that if we found PTEN-deleted HGPIN lesions near carcinoma in which all carcinoma and HGPIN cells showed the identical TMPRSS2-ERG rearrangement breakpoint, but only part of the invasive adenocarcinoma had PTEN-deletion, then the HGPIN lesion would most likely represent retrograde glandular colonization of the PTEN deleted invasive carcinoma, which itself arose after invasion and subsequent to TMPRSS2-ERG fusion. To formally test this we made use of TMPRSS2-ERG breakpoint data at nucleotide resolution that were previously determined by our group (geBACS, Supplementary Figure 4) (34) . We identified 7 independent cases for which nucleotide resolution TMPRSS2-ERG breakpoint information and FFPE material was available (Figure 3, Supplementary Table 1) . Guided by the immunohistochemistry for ERG, a total of 44 neoplastic lesions of different morphologies and adjacent normal glands were microdissected. Extracted DNA was amplified with rearrangement-specific primers and amplicons were sequence verified (Figure 2, Supplementary Figure 4) . In 6/7 cases, ERG overexpression resulted from a fusion between TMPRSS2 intron one or two and ERG intron three (34) . A single case (case 989) harboured a fusion between a previously uncharacterized 5' fusion partner, FAM177A1 (chromosome 14) and ERG, which was associated with ERG overexpression (Supplementary Figure 6) .
In 7/7 analyzed cases, all ERG-positive lesions within each case shared the same ERG breakpoint indicating a common monoclonal origin (Figure 2, 3, Supplementary Figures 6-11 ).
Adjacent microdissected normal tissue or control white blood cell DNA (WBC) showed no evidence of TMPRSS2-ERG rearrangements (Figure 2, Supplementary Figures 6-11 ) documenting the specificity of the assay. Notably, all microdissected partially ERG-positive HGPIN lesions, as well as stereotypical complete gland HGPIN lesions, showed the same genomic breakpoint as the adjacent index invasive carcinoma establishing that HGPIN and partial ERG-positive HGPIN lesions share the same clonal origin as the invasive carcinoma lesions (Figure 2, 3, Supplementary Figures 6-11) . For example, these clonal relationships are evident in case 808 in lesions 2, 5 and 6, which represent partial positive lesions, and microdissected focus 4, which represents full gland HGPIN and cribriform HGPIN (Figure 2) . Of note, in case 995 (Supplementary Figure 7) we observed complex genomic rearrangements which encompassed an intergenic TMPRSS2-ERG rearrangement and intragenic rearrangements within the TMPRSS2 gene (34) . Importantly, the genomic rearrangement breakpoints underlying these complex rearrangements were observed in all evaluated lesions of this case. This finding is consistent with the model of chromoplexy suggesting that a single event, occurring early during cancer progression, likely resulted in this genomic alteration (2, 34) . In addition to HGPIN lesions, we found similar clonal Accepted Article relationships between invasive carcinoma lesions and adjacent IDC-P lesions (Supplementary Figures   7, 8, 9 and 11 ).
To assess PTEN deletion status we used a previously validated immunohistochemical protocol as well as fluorescence in situ hybridization (FISH). Homozygous loss of the tumour suppressor gene PTEN often occurs in a subclonal fashion, which allows delineation of temporal and spatial directionality of clonal evolutionary relationships between lesions (2,7,26,37,55). We found regions of homozygous loss of PTEN and concomitant loss or marked decrease in PTEN protein expression in 6/7 cases in which we had nucleotide resolution ERG breakpoint data. As expected, in invasive carcinoma lesions, PTEN loss appeared more heterogeneous than ERG overexpression, as 4/6 ERG-positive cases (Figure 3, case 4 , 808, 814, 989, Figure 4) showed PTEN loss in only a subset of tumour glands as opposed to ERG staining which occurred in all tumour cells. We observed that in 4/4 cases with heterogeneous PTEN loss in the nearby invasive adenocarcinoma lesion, partial ERG-positive HGPIN, full gland ERG-positive HGPIN, and ERG-positive IDC-P lesions showed loss of PTEN (Figure 2, 3) . It is worth noting that, regardless of PTEN status, all lesions dissected from a given individual case harboured the identical TMPRSS2-ERG breakpoint, strongly supporting a common monoclonal origin and suggesting that the differences in PTEN status are most likely due to subclonal evolution and not to sampling of a collision tumour of phylogenetically diverse lesions. Based on these observations the most likely model is that all neoplastic lesions in the analyzed cases have the same clonal origin based on the fact that they share the This article is protected by copyright. All rights reserved.
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This notion is indirectly supported by other findings. For example a number of studies demonstrating that HGPIN lesions that are isolated, or distant from cancer lesions, show genomic alterations such as ERG rearrangements and PTEN copy number loss with much lower frequency than those in close proximity to invasive carcinomas (32, 43, 56) . Furthermore, we show that partially ERGpositive HGPIN lesions can be found frequently adjacent to invasive cancer lesions irrespective of tumour grade. Such lesions show identical ERG breakpoints with all adjacent invasive lesions establishing in an unequivocal manner a direct clonal relationship. In addition, it is important to note that many ERG-positive HGPIN lesions often occurred as only a relatively small group of cells within an otherwise normal appearing gland. Since this distribution pattern of ERG-positive cells is highly prevalent in lesions adjacent to invasive cancer (Table 1) , and the majority of such lesions share the same ERG breakpoint, it is unlikely that such lesions represent de novo HGPIN lesions.
The misclassification of lesions representing invasive disease as pre-invasive has the potential for erroneous clinical decision making, since it is possible that invasive carcinoma that is mimicking a precursor lesion could even represent an aggressive cancer. Although the diagnostic utility remains controversial, two recent studies provide evidence that cases with ERG-positive HGPIN are more likely to show invasive cancer on subsequent biopsies as compared to cases that show no ERG expression in HGPIN (15, 57) . Most notably Park et al. showed that the rate of cancer diagnosis in a subsequent biopsy is increased from 35% in patients with ERG negative HGPIN to 53% in patients with ERG positive HGPIN (15) . Our present findings suggest that a significant fraction of the ERG-positive HGPIN cases likely represent ductal/acinar spreading of an adjacent, but inadequately sampled invasive carcinoma. This could explain the higher rates of cancer on repeat biopsy for ERG-positive HGPIN lesions. In our previous studies, and those of others, the rates of PTEN loss in isolated HGPIN lesions is very low (26, 58) , while those rates in IDC-P are very high (44, 58) . In the present study the rates of PTEN loss in HGPIN, and partially involved HGPIN in lesions in close proximity to invasive carcinoma were very high. Therefore it is important for additional studies to address whether IHC staining or FISH assays for ERG and PTEN could be helpful in determining which patients with isolated HGPIN on biopsy may require more intensive clinical follow-up.
There is still an ongoing evolution among pathologists about the precise morphological criteria and clinical relevance of intraepithelial cribriform lesions in the prostate (48) (49) (50) 53) . It is important to note that the defining diagnostic criteria were established based on histomorphologic evidence only. IDC-P for instance has been suggested as a defined morphological entity that is associated with worse prognosis (48) (49) (50) . More recent cytogenetic and IHC studies suggested a clonal relationship with adjacent invasive prostate cancer based on ERG (42, 59) . In the present study, a subset of cases for which clonality was addressed using TMPRSS2-ERG breakpoint analysis contained IDC-P. The breakpoints in such cases were identical in invasive carcinoma and IDC-P, providing strong evidence for the shared clonal origin of these lesions (Figure 3) . Furthermore, the majority of IDC-P lesions evaluated in this study also exhibited PTEN loss similar to the adjacent adenocarcinoma that showed subclonal PTEN loss, suggesting again that the IDC-P occurred subsequent to invasive carcinoma development. Retrograde spread of acinar Accepted Article carcinoma into ducts is widely accepted among pathologists to occur in IDC-P (44, 50) , this study provides first definitive evidence for this notion.
The current study has several limitations. Due to the small size of lesions and the lack of large scale sequencing data, the clonal inferences were restricted to the assessment of only two index genomic alterations (ERG, PTEN). Despite offering a first opportunity to decipher both direct clonal and temporal evolutionary relationships, the restriction to two genomic markers did not allow a detailed phylogenetic analysis. Therefore important questions about additional subclonal evolution and co-occurring genomic and epigenetic alterations could not be addressed. Future studies using a larger panel of genomic index alterations and genome wide analytical tools will be helpful to validate and extend our findings. (60), (45) . It is therefore possible that ERGpositive prostate cancers may be particularly prone to intra-acinar spread and retrograde glandular colonization. Finally, we focused on lesions that were in close proximity to cancer. It will be interesting in subsequent studies to determine how often lesions completely separate from cancer that morphologically resemble HGPIN might actually represent invasive carcinoma. This article is protected by copyright. All rights reserved. Accepted Article 
